130 related articles for article (PubMed ID: 2622863)
1. Macromolecular prodrugs. XVI. Colon-targeted delivery--comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract.
Larsen C; Harboe E; Johansen M; Olesen HP
Pharm Res; 1989 Dec; 6(12):995-9. PubMed ID: 2622863
[TBL] [Abstract][Full Text] [Related]
2. Stability of ketoprofen-dextran ester prodrugs in homogenates of various segments of the pig GI tract.
Larsen C; Jensen BH; Olesen HP
Acta Pharm Nord; 1991; 3(1):41-4. PubMed ID: 1713035
[TBL] [Abstract][Full Text] [Related]
3. Macromolecular prodrugs. XV. Colon-targeted delivery--bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig.
Harboe E; Larsen C; Johansen M; Olesen HP
Pharm Res; 1989 Nov; 6(11):919-23. PubMed ID: 2480587
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
McLeod AD; Friend DR; Tozer TN
J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
[TBL] [Abstract][Full Text] [Related]
5. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity.
Aboul-Fadl T; Al-Hamad SS; Fouad EA
Bioorg Chem; 2018 Feb; 76():370-379. PubMed ID: 29241109
[TBL] [Abstract][Full Text] [Related]
7. Preliminary studies on the in vivo fate of FITC-dextrans and naproxen-dextran ester prodrugs administered i.v. to rabbits.
Kurtzhals P; Larsen C
Acta Pharm Nord; 1989; 1(4):201-10. PubMed ID: 2480144
[TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of dextran-naproxen ester pro-drugs with varying molecular weights and degrees of substitution in biological media by means of high-performance size exclusion chromatography with fluorescence detection.
Larsen C
J Pharm Biomed Anal; 1989; 7(10):1173-81. PubMed ID: 2484990
[TBL] [Abstract][Full Text] [Related]
9. In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media.
Hirayama F; Minami K; Uekama K
J Pharm Pharmacol; 1996 Jan; 48(1):27-31. PubMed ID: 8722490
[TBL] [Abstract][Full Text] [Related]
10. Macromolecular prodrugs. XX. Factors influencing model dextranase-mediated depolymerization of dextran derivatives in vitro.
Nielsen LS; Weibel H; Johansen M; Larsen C
Acta Pharm Nord; 1992; 4(1):23-30. PubMed ID: 1381183
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.
Kim W; Yang Y; Kim D; Jeong S; Yoo JW; Yoon JH; Jung Y
Drug Des Devel Ther; 2017; 11():419-429. PubMed ID: 28243064
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
[TBL] [Abstract][Full Text] [Related]
13. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
Minami K; Hirayama F; Uekama K
J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig.
Larsen C; Jensen BH; Olesen HP
Acta Pharm Nord; 1991; 3(2):71-6. PubMed ID: 1716910
[TBL] [Abstract][Full Text] [Related]
15. Biological and metabolic study of naproxen-propyphenazone mutual prodrug.
Sheha M; Khedr A; Elsherief H
Eur J Pharm Sci; 2002 Nov; 17(3):121-30. PubMed ID: 12393139
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy.
Lee Y; Kim IH; Kim J; Yoon JH; Shin YH; Jung Y; Kim YM
J Drug Target; 2011 Jun; 19(5):336-43. PubMed ID: 20615092
[TBL] [Abstract][Full Text] [Related]
17. Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation.
Rautio J; Nevalainen T; Taipale H; Vepsäläinen J; Gynther J; Laine K; Järvinen T
Eur J Pharm Sci; 2000 Aug; 11(2):157-63. PubMed ID: 10915963
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid.
Jung YJ; Lee JS; Kim HH; Kim YT; Kim YM
Arch Pharm Res; 1998 Apr; 21(2):179-86. PubMed ID: 9875428
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid.
Lee JS; Jung YJ; Doh MJ; Kim YM
Drug Dev Ind Pharm; 2001 Apr; 27(4):331-6. PubMed ID: 11411900
[TBL] [Abstract][Full Text] [Related]
20. Diacyl glyceryl ester prodrugs for slow release in the skin: synthesis and in vitro degradation and absorption studies for naproxen derivatives.
Thorsteinsson T; Másson M; Loftsson T; Haraldsson GG; Stefánsson E
Pharmazie; 1999 Nov; 54(11):831-6. PubMed ID: 10603609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
